Author:
Jin Shasha,Paludetto Marie-Noëlle,Kurkela Mika,Kahma Helinä,Neuvonen Mikko,Xiang Xiaoqiang,Cai Weimin,Backman Janne T.
Funder
Sigrid Jusélius Foundation
National Natural Science Foundation of China
HUS Helsinki University Hospital
China Scholarship Council
Academy of Finland
Reference116 articles.
1. Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects;Abbas;Clin. Ther.,2012
2. Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans;Bathala;Drug Metab. Dispos. Biol. Fate Chem.,2012
3. Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation;Bi;Mol. Pharm.,2018
4. A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE);Bullock;Cancer Chemother. Pharmacol.,2011
5. Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer;Calvert;Anticancer. Drugs,2014